Aperio Group’s Boston Scientific BSX Stock Holding History

Aperio Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$23.3M	Sell	648,532 -100,286	-13%	-$3.61M	0.07%	277
2020 Q3	$28.6M	Buy	748,818 +25,716	+4%	+$983K	0.1%	200
2020 Q2	$25.4M	Buy	723,102 +13,103	+2%	+$460K	0.09%	212
2020 Q1	$23.2M	Sell	709,999 -66,805	-9%	-$2.18M	0.1%	204
2019 Q4	$35.1M	Sell	776,804 -7,745	-1%	-$350K	0.13%	181
2019 Q3	$31.9M	Buy	784,549 +13,506	+2%	+$550K	0.13%	185
2019 Q2	$33.1M	Buy	771,043 +18,861	+3%	+$811K	0.14%	166
2019 Q1	$28.9M	Buy	752,182 +41,384	+6%	+$1.59M	0.12%	180
2018 Q4	$25.1M	Buy	710,798 +49,134	+7%	+$1.74M	0.13%	182
2018 Q3	$25.5M	Buy	661,664 +14,068	+2%	+$542K	0.11%	202
2018 Q2	$21.2M	Buy	647,596 +74,481	+13%	+$2.44M	0.1%	225
2018 Q1	$15.7M	Buy	573,115 +53,708	+10%	+$1.47M	0.08%	301
2017 Q4	$12.9M	Buy	519,407 +2,830	+0.5%	+$70.2K	0.07%	349
2017 Q3	$15.1M	Buy	516,577 +57,485	+13%	+$1.68M	0.09%	280
2017 Q2	$12.7M	Buy	459,092 +45,335	+11%	+$1.26M	0.08%	304
2017 Q1	$10.3M	Buy	413,757 +32,405	+8%	+$806K	0.07%	335
2016 Q4	$8.25M	Sell	381,352 -54,069	-12%	-$1.17M	0.06%	359
2016 Q3	$10.4M	Buy	435,421 +31,151	+8%	+$741K	0.08%	306
2016 Q2	$9.45M	Buy	404,270 +38,322	+10%	+$896K	0.07%	311
2016 Q1	$6.88M	Buy	365,948 +56,127	+18%	+$1.06M	0.06%	372
2015 Q4	$5.71M	Buy	309,821 +31,265	+11%	+$577K	0.05%	418
2015 Q3	$4.57M	Buy	278,556 +36,084	+15%	+$592K	0.05%	451
2015 Q2	$4.29M	Buy	242,472 +36,335	+18%	+$643K	0.04%	462
2015 Q1	$3.66M	Buy	206,137 +25,160	+14%	+$447K	0.04%	493
2014 Q4	$2.4M	Buy	180,977 +3,591	+2%	+$47.6K	0.03%	587
2014 Q3	$2.1M	Sell	177,386 -7,108	-4%	-$83.9K	0.03%	599
2014 Q2	$2.36M	Buy	184,494 +13,637	+8%	+$174K	0.03%	547
2014 Q1	$2.31M	Buy	+170,857	New	+$2.31M	0.03%	657
2013 Q4	–	Sell	-142,334	Closed	-$1.67M	–	677
2013 Q3	$1.67M	Buy	142,334 +36,589	+35%	+$430K	0.03%	652
2013 Q2	$980K	Buy	+105,745	New	+$980K	0.02%	765